314 related articles for article (PubMed ID: 20805979)
21. Down-regulation of uPAR and uPA activates caspase-mediated apoptosis and inhibits the PI3K/AKT pathway.
Gondi CS; Kandhukuri N; Dinh DH; Gujrati M; Rao JS
Int J Oncol; 2007 Jul; 31(1):19-27. PubMed ID: 17549401
[TBL] [Abstract][Full Text] [Related]
22. Angiogenin interacts with the plasminogen activation system at the cell surface of breast cancer cells to regulate plasmin formation and cell migration.
Dutta S; Bandyopadhyay C; Bottero V; Veettil MV; Wilson L; Pins MR; Johnson KE; Warshall C; Chandran B
Mol Oncol; 2014 May; 8(3):483-507. PubMed ID: 24457100
[TBL] [Abstract][Full Text] [Related]
23. Specific interference of urokinase-type plasminogen activator receptor and matrix metalloproteinase-9 gene expression induced by double-stranded RNA results in decreased invasion, tumor growth, and angiogenesis in gliomas.
Lakka SS; Gondi CS; Dinh DH; Olivero WC; Gujrati M; Rao VH; Sioka C; Rao JS
J Biol Chem; 2005 Jun; 280(23):21882-92. PubMed ID: 15824107
[TBL] [Abstract][Full Text] [Related]
24. VEGF-initiated angiogenesis and the uPA/uPAR system.
Breuss JM; Uhrin P
Cell Adh Migr; 2012; 6(6):535-615. PubMed ID: 23076133
[TBL] [Abstract][Full Text] [Related]
25. RNAi-mediated downregulation of urokinase plasminogen activator receptor and matrix metalloprotease-9 in human breast cancer cells results in decreased tumor invasion, angiogenesis and growth.
Kunigal S; Lakka SS; Gondi CS; Estes N; Rao JS
Int J Cancer; 2007 Nov; 121(10):2307-16. PubMed ID: 17657740
[TBL] [Abstract][Full Text] [Related]
26. Radiation-inducible silencing of uPA and uPAR in vitro and in vivo in meningioma.
Rao Gogineni V; Kumar Nalla A; Gupta R; Gorantla B; Gujrati M; Dinh DH; Rao JS
Int J Oncol; 2010 Apr; 36(4):809-16. PubMed ID: 20198323
[TBL] [Abstract][Full Text] [Related]
27. Activation of urokinase plasminogen activator and its receptor axis is essential for macrophage infiltration in a prostate cancer mouse model.
Zhang J; Sud S; Mizutani K; Gyetko MR; Pienta KJ
Neoplasia; 2011 Jan; 13(1):23-30. PubMed ID: 21245937
[TBL] [Abstract][Full Text] [Related]
28. Amino-terminal fragment of urokinase inhibits tumor cell invasion in vitro and in vivo: respective contribution of the urokinase plasminogen activator receptor-dependent or -independent pathway.
Li H; Soria C; Griscelli F; Opolon P; Soria J; Yeh P; Legrand C; Vannier JP; Belin D; Perricaudet M; Lu H
Hum Gene Ther; 2005 Oct; 16(10):1157-67. PubMed ID: 16218777
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of uPAR promotes urokinase translocation into the nucleus and epithelial to mesenchymal transition in neuroblastoma.
Semina EV; Rubina KA; Shmakova AA; Rysenkova KD; Klimovich PS; Aleksanrushkina NA; Sysoeva VY; Karagyaur MN; Tkachuk VA
J Cell Physiol; 2020 Sep; 235(9):6268-6286. PubMed ID: 31990070
[TBL] [Abstract][Full Text] [Related]
30. Urokinase and urokinase receptor participate in regulation of neuronal migration, axon growth and branching.
Semina E; Rubina K; Sysoeva V; Rysenkova K; Klimovich P; Plekhanova O; Tkachuk V
Eur J Cell Biol; 2016 Sep; 95(9):295-310. PubMed ID: 27324124
[TBL] [Abstract][Full Text] [Related]
31. Expression of urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor and maspin in oral squamous cell carcinoma: Association with mode of invasion and clinicopathological factors.
Yoshizawa K; Nozaki S; Kitahara H; Kato K; Noguchi N; Kawashiri S; Yamamoto E
Oncol Rep; 2011 Dec; 26(6):1555-60. PubMed ID: 21833477
[TBL] [Abstract][Full Text] [Related]
32. A hybrid protein comprising ATF domain of pro-UK and VAS, an angiogenesis inhibitor, is a potent candidate for targeted cancer therapy.
Sun Q; Xu Q; Dong X; Cao L; Huang X; Hu Q; Hua ZC
Int J Cancer; 2008 Aug; 123(4):942-50. PubMed ID: 18528863
[TBL] [Abstract][Full Text] [Related]
33. Inactivation of uPA and its receptor uPAR by 3,3'-diindolylmethane (DIM) leads to the inhibition of prostate cancer cell growth and migration.
Ahmad A; Kong D; Sarkar SH; Wang Z; Banerjee S; Sarkar FH
J Cell Biochem; 2009 Jun; 107(3):516-27. PubMed ID: 19330806
[TBL] [Abstract][Full Text] [Related]
34. PTEN expression in endothelial cells is down-regulated by uPAR to promote angiogenesis.
Unseld M; Chilla A; Pausz C; Mawas R; Breuss J; Zielinski C; Schabbauer G; Prager GW
Thromb Haemost; 2015 Aug; 114(2):379-89. PubMed ID: 25925849
[TBL] [Abstract][Full Text] [Related]
35.
Rasouli BS; Ghadimi-Darsajini A; Nekouian R; Iragian GR
J Cancer Res Ther; 2017; 13(2):246-251. PubMed ID: 28643742
[TBL] [Abstract][Full Text] [Related]
36. The inhibitory effect of HKa in endothelial cell tube formation is mediated by disrupting the uPA-uPAR complex and inhibiting its signaling and internalization.
Liu Y; Cao DJ; Sainz IM; Guo YL; Colman RW
Am J Physiol Cell Physiol; 2008 Jul; 295(1):C257-67. PubMed ID: 18495808
[TBL] [Abstract][Full Text] [Related]
37. β-Catenin and NF-κB cooperate to regulate the uPA/uPAR system in cancer cells.
Moreau M; Mourah S; Dosquet C
Int J Cancer; 2011 Mar; 128(6):1280-92. PubMed ID: 20473943
[TBL] [Abstract][Full Text] [Related]
38. Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori.
Iwamoto J; Mizokami Y; Takahashi K; Nakajima K; Ohtsubo T; Miura S; Narasaka T; Takeyama H; Omata T; Shimokobe K; Ito M; Takehara H; Matsuoka T
Scand J Gastroenterol; 2005 Jul; 40(7):783-93. PubMed ID: 16109653
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms by which cleaved kininogen inhibits endothelial cell differentiation and signalling.
Colman RW; Wu Y; Liu Y
Thromb Haemost; 2010 Nov; 104(5):875-85. PubMed ID: 20886177
[TBL] [Abstract][Full Text] [Related]
40. Urokinase receptor associates with myocardin to control vascular smooth muscle cells phenotype in vascular disease.
Kiyan Y; Limbourg A; Kiyan R; Tkachuk S; Limbourg FP; Ovsianikov A; Chichkov BN; Haller H; Dumler I
Arterioscler Thromb Vasc Biol; 2012 Jan; 32(1):110-22. PubMed ID: 22075245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
